New Orleans, LA, United States of America

David H Coy

USPTO Granted Patents = 100 (Patent Applications = 6)

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 2.3

ph-index = 18

Forward Citations = 1,095(Granted Patents)

Forward Citations (Not Self Cited) = 1,009(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Metairie, LA (US) (2016)
New Orleans, LA (US) (1977 - 2021)

Company Filing History:

53 out of 240

The Administrators of the Tulane Educational Fund

patents

10 out of 52

Biomeasure Incorporated

The Rockefeller University

patents

5. 2 out of 47

Societe De Conseils De Recherches Et D'applications Scientifiques Sas

patents

6. 2 out of 249

Auckland Uniservices Limited

patents

7. 2 out of 3,580

American Cyanamid Company

patents

8. 2 out of 8

Tulane Educational Fund

patents

9. 1 out of 817

Louisiana State University and Agricultural & Mechanical College

The Ohio State University

patents

12. 1 out of 2

The United States of America As Represented by the Veterans

patents

13. 1 out of 1

Tulane Univ. Medical Ctr.

Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.)

patents

17. 1 out of 4

The Administration of the Tulane Educational Fund

patents

18. 38 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 1977-2025

Loading Chart...

Areas of Expertise:

Conjugates

Ghrelin Receptor Antagonists

Somatostatin Antagonists

Flavivirus Fusion Inhibitors

Peptide Analogues

Therapeutic Peptides

Bone Disorder Treatments

Growth Hormone-Releasing Peptides

PACAP Analogues

Cyclic Peptide Analogs

Neuromedin B Receptor Antagonists

Diagnostic Therapeutics

100 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12377157 - Conjugates, their compositions, and their related methods (2025-08-05),

2. 10913780 - Conjugates, their compositions, their uses, and their methods of making (2021-02-09),

3. 9724381 - Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof (2017-08-08),

4. 9358272 - Multicomponent compositions and their uses (2016-06-07),

5. 9353171 - Use of pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP analogs for treating contrast-induced nephropathy (2016-05-31),

6. 9315546 - Growth hormone secretatogue receptor antagonists and uses thereof (2016-04-19),

7. 9220760 - Method of modulating the proliferation of medullary thyroid carcinoma cells (2015-12-29),

8. 9133262 - Somatostatin antagonists (2015-09-15),

9. 8916517 - Analogs of pituitary adenylate cyclase-activating polypeptide (PACAP) and methods for their use (2014-12-23),

10. 8883721 - Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof (2014-11-11),

11. 8536120 - Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof (2013-09-17),

12. 8153360 - Flavivirus fusion inhibitors (2012-04-10),

13. 7854937 - Flavivirus fusion inhibitors (2010-12-21),

14. 7771727 - Conjugates of therapeutic or cytotoxic agents and biologically active peptides (2010-08-10),

15. 7550423 - Somatostatin antagonists (2009-06-23),

Title: The Innovative Journey of David H Coy

Introduction: David H Coy, a pioneering inventor based in New Orleans, LA (US), has made significant contributions to the field of innovations with his creative mindset and dedication to problem-solving.

Latest Patents: David H Coy holds several patents in various industries, showcasing his versatility and ingenuity in inventing new solutions to complex challenges. His most recent patents focus on cutting-edge technologies in the healthcare and environmental sectors.

Career Highlights: Throughout his illustrious career, David H Coy has been recognized for his groundbreaking inventions that have had a positive impact on society. His innovative spirit and commitment to excellence have led to the successful development of products that improve the quality of life for many.

Collaborations: David H Coy has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the successful implementation of his innovative ideas.

Conclusion: In conclusion, David H Coy stands as a shining example of an inventor who has consistently pushed the boundaries of what is possible through his creativity and determination. His contributions to the world of innovations continue to inspire future generations of inventors to think outside the box and strive for excellence in their pursuits.

This text is generated by artificial intelligence and may not be accurate.